Kayoko Minakata Selected Research

diphenidine

3/2016

Identification and quantification of metabolites of AB-CHMINACA in a urine specimen of an abuser.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kayoko Minakata Research Topics

Disease

5	Poisoning 01/2022 - 03/2016
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Vomiting 09/2020
1	Lactic Acidosis 09/2020
1	Asphyxia (Suffocation) 09/2020
1	Diabetes Mellitus 09/2020
1	Heart Failure 01/2011
1	Neoplasms (Cancer) 01/2009
1	Ascorbic Acid Deficiency (Vitamin C Deficiency) 01/2004

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 09/2018 - 02/2018
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	benzimidazoleIBA 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	BuforminIBA 09/2020
1	AcidsIBA 09/2018
1	Zolpidem (Ambien)FDA LinkGeneric 09/2018
1	CannabinoidsIBA 02/2018
1	MAB-CHMINACAIBA 02/2018
1	N- (1- (aminocarbonyl)- 2- methylpropyl)- 1- (cyclohexylmethyl)- 1H- indazole- 3- carboxamideIBA 03/2016
1	diphenidineIBA 03/2016
1	Cardiac GlycosidesIBA 01/2011
1	PolymersIBA 01/2011
1	arseniteIBA 01/2009
1	Arsenicals (Arsenic Compounds)IBA 01/2009
1	MineralsIBA 01/2004